SPL-707

CAT: 0804-HY-111360-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-111360-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SPL-707 is an orally active, selective signal peptide peptidase-like 2a (SPPL2a) inhibitor with an IC50 of 77 nM for hSPPL2a. SPL-707 inhibits γ-secretase (IC50=6.1 μM) and SPP (IC50=3.7 μM) . SPL-707 has the potential for autoimmune diseases research by targeting B cells and dendritic cells[1].
CAS Number
[2195361-33-0]
UNSPSC
12352005
Target
γ-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/SPL-707.html
Purity
99.64
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(NC(C[C@@H](C2CC2)C(N[C@@H]3C(N(CC4(CC4)C5)N5C(C6=C3C=CC=C6)=O)=O)=O)=O)C=C(F)C=N1
Molecular Formula
C27H28FN5O4
Molecular Weight
505.54
References & Citations
[1]Velcicky J, et al. Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. J Med Chem. 2018 Feb 8;61 (3) :865-880.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-112081-01BAY-707
HY-P991628-01SSGJ-707
HY-114877CG-707
HY-P991093NGM-707
HY-163128SPL-IN-1
HY-110295SPL-334
HY-128356-01SPL-410
HY-112081ABAY-707 (acetate)
HY-W927726CRBN ligand-707
HY-RI03884-01Mmu-miR-707 inhibitor

Alternative Products

CatalogName
MBS387987-01SPL-707
A13669-1SPL-707 1mg
A13669-5SPL-707 5mg
A13669-10SPL-707 10mg
MBS8560235-01SPL
257013-01UCM 707
MBS3603353-01BAY-707
T9901A-1886-01SSGJ-707
5367/10SGC 707
6562/25BAY 707

Popular Products